Skip to main content
Erschienen in: Journal of Genetic Counseling 6/2010

01.12.2010 | Original Research

Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences

verfasst von: Andrew Smart

Erschienen in: Journal of Genetic Counseling | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

This paper reports data from a qualitative study of patient experiences of DNA testing and cascade screening for hypertrophic cardiomyopathy and long QT syndrome, cardiac conditions that place sufferers at risk of sudden death. The paper particularly focuses on potential impediments to testing and screening. Semi-structured interviews were undertaken with a purposive sample of 27 people in the UK who had undergone testing. In the context of the uncertainties that can characterize experiences of these disorders, the majority of participants in this sample embraced testing and screening as a way of providing health information for themselves or their relatives (particularly children). There was nevertheless evidence of ambivalence about the value and impact of the DNA test information which could influence participants’ dispositions toward testing, and play into dilemmas about family communication. Other concerns arose in relation to communicating about these disorders, decisions to involve elderly relatives and pressures relating to family responsibility. The evidence of ambivalence provides insight into why some people may be resistant to testing, screening and sharing information. The findings about communication processes indicate potential areas of concern for the cascading process.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Alcalai, R., Seidman, J. G., & Seidman, C. E. (2008). Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. Journal of Cardiovascular Electrophysiolology, 19, 104–110. Alcalai, R., Seidman, J. G., & Seidman, C. E. (2008). Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. Journal of Cardiovascular Electrophysiolology, 19, 104–110.
Zurück zum Zitat Andersen, J., Øyen, N., Bjorvatn, C., & Gjengedal, E. (2008). Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death. Journal of Genetic Counseling, 17, 489–498.CrossRefPubMed Andersen, J., Øyen, N., Bjorvatn, C., & Gjengedal, E. (2008). Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death. Journal of Genetic Counseling, 17, 489–498.CrossRefPubMed
Zurück zum Zitat Bazeley, P., & Richards, L. (2000). The NVivo qualitative project book. London: Sage. Bazeley, P., & Richards, L. (2000). The NVivo qualitative project book. London: Sage.
Zurück zum Zitat Charron, P., Héron, D., Gargiulo, M., Richard, P., Dubourg, O., Desnos, M., et al. (2002). Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. Journal of Medical Genetics, 39, 741–746.CrossRefPubMed Charron, P., Héron, D., Gargiulo, M., Richard, P., Dubourg, O., Desnos, M., et al. (2002). Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. Journal of Medical Genetics, 39, 741–746.CrossRefPubMed
Zurück zum Zitat Chiang, C. E. (2004). Congenital and acquired long QT syndrome. Current concepts and management. Cardiology in Review, 12, 222–234.CrossRefPubMed Chiang, C. E. (2004). Congenital and acquired long QT syndrome. Current concepts and management. Cardiology in Review, 12, 222–234.CrossRefPubMed
Zurück zum Zitat Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. A., & van Langen, I. M. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201–1207.CrossRefPubMed Christiaans, I., Birnie, E., Bonsel, G. J., Wilde, A. A., & van Langen, I. M. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16, 1201–1207.CrossRefPubMed
Zurück zum Zitat Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009a). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. American Journal of Medical Genetics, 149A, 602–612.CrossRefPubMed Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009a). Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. American Journal of Medical Genetics, 149A, 602–612.CrossRefPubMed
Zurück zum Zitat Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009b). Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. American Journal of Medical Genetics, 149A, 1444–1451.CrossRefPubMed Christiaans, I., van Langen, I. M., Birnie, E., Bonsel, G. J., Wilde, A. A., & Smets, E. M. (2009b). Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. American Journal of Medical Genetics, 149A, 1444–1451.CrossRefPubMed
Zurück zum Zitat Clarke, A., Richards, M., Kerzin-Storrar, L., Halliday, J., Young, M. A., Simpson, S. A., et al. (2005). Genetic professionals’ reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics, 13, 556–562.CrossRefPubMed Clarke, A., Richards, M., Kerzin-Storrar, L., Halliday, J., Young, M. A., Simpson, S. A., et al. (2005). Genetic professionals’ reports of nondisclosure of genetic risk information within families. European Journal of Human Genetics, 13, 556–562.CrossRefPubMed
Zurück zum Zitat Cox, S., O’Donoghue, A., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with Hypertrophic Cardiomyopathy. Heart, 78, 182–187.PubMed Cox, S., O’Donoghue, A., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with Hypertrophic Cardiomyopathy. Heart, 78, 182–187.PubMed
Zurück zum Zitat Crotti, L., Celano, G., Dagradi, F., & Schwartz, P. J. (2008). Congenital long QT syndrome. Orphanet Journal of Rare Diseases, 3, 18.CrossRefPubMed Crotti, L., Celano, G., Dagradi, F., & Schwartz, P. J. (2008). Congenital long QT syndrome. Orphanet Journal of Rare Diseases, 3, 18.CrossRefPubMed
Zurück zum Zitat De Wert, G. (2005). Cascade screening: whose information is it anyway? European Journal of Human Genetics, 13, 397–398.CrossRefPubMed De Wert, G. (2005). Cascade screening: whose information is it anyway? European Journal of Human Genetics, 13, 397–398.CrossRefPubMed
Zurück zum Zitat Dey, I. (1993). Qualitative data analysis: A user-friendly guide for social scientists. London: Routledge.CrossRef Dey, I. (1993). Qualitative data analysis: A user-friendly guide for social scientists. London: Routledge.CrossRef
Zurück zum Zitat Farnsworth, M. M., Fosyth, D., Haglund, C., & Ackerman, M. J. (2006). When I go in to wake them...I wonder: parental perceptions about congenital long QT syndrome. Journal of the American Academy of Nurse Practitioners, 18, 284–290.CrossRefPubMed Farnsworth, M. M., Fosyth, D., Haglund, C., & Ackerman, M. J. (2006). When I go in to wake them...I wonder: parental perceptions about congenital long QT syndrome. Journal of the American Academy of Nurse Practitioners, 18, 284–290.CrossRefPubMed
Zurück zum Zitat Gaff, C. L., Clarke, A. J., Atkinson, P., Sivell, S., Elwyn, G., Iredale, R., et al. (2007). Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics, 15, 999–1011.CrossRefPubMed Gaff, C. L., Clarke, A. J., Atkinson, P., Sivell, S., Elwyn, G., Iredale, R., et al. (2007). Process and outcome in communication of genetic information within families: a systematic review. European Journal of Human Genetics, 15, 999–1011.CrossRefPubMed
Zurück zum Zitat Gomm, R. (2004). Social research methodology. A critical introduction. Basingstoke: Palgrave MacMillan. Gomm, R. (2004). Social research methodology. A critical introduction. Basingstoke: Palgrave MacMillan.
Zurück zum Zitat Hintsa, T., Keltikangas-Jarvinen, L., Puttonen, S., Ravaja, N., Toivonen, L., Kontula, K., et al. (2009). Depressive symptoms in the congenital long QT syndrome. Annals of Medicine, 23, 1–6.CrossRef Hintsa, T., Keltikangas-Jarvinen, L., Puttonen, S., Ravaja, N., Toivonen, L., Kontula, K., et al. (2009). Depressive symptoms in the congenital long QT syndrome. Annals of Medicine, 23, 1–6.CrossRef
Zurück zum Zitat Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., et al. (2009). The genetic basis of long QT and short QT syndromes: a mutation update. Human Mutation, 30(11), 1486–1511.CrossRefPubMed Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., et al. (2009). The genetic basis of long QT and short QT syndromes: a mutation update. Human Mutation, 30(11), 1486–1511.CrossRefPubMed
Zurück zum Zitat Hendriks, K. S. W. H., Grosfeld, F. J. M., van Tintelen, J. P., van Langen, I. M., Wilde, A. A. M., van den Bout, J., et al. (2005). Can parents adjust to the idea that their child is at risk for a sudden death? Psychological impact of risk for QT syndrome. American Journal of Medical Genetics, 138(2), 107–112. Hendriks, K. S. W. H., Grosfeld, F. J. M., van Tintelen, J. P., van Langen, I. M., Wilde, A. A. M., van den Bout, J., et al. (2005). Can parents adjust to the idea that their child is at risk for a sudden death? Psychological impact of risk for QT syndrome. American Journal of Medical Genetics, 138(2), 107–112.
Zurück zum Zitat Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.CrossRefPubMed Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.CrossRefPubMed
Zurück zum Zitat Ingles, J., Lind, J. M., Phongsavan, P., & Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10, 117–120.CrossRefPubMed Ingles, J., Lind, J. M., Phongsavan, P., & Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10, 117–120.CrossRefPubMed
Zurück zum Zitat Keenan, K. F., Simpson, S. A., Wilson, B. J., Van Teijlingen, E. R., McKee, L., Haites, N., et al. (2005). ‘It’s their blood not mine’: who’s responsible for (not) telling relatives about genetic risk? Health Risk & Society, 7, 209–226.CrossRef Keenan, K. F., Simpson, S. A., Wilson, B. J., Van Teijlingen, E. R., McKee, L., Haites, N., et al. (2005). ‘It’s their blood not mine’: who’s responsible for (not) telling relatives about genetic risk? Health Risk & Society, 7, 209–226.CrossRef
Zurück zum Zitat Keren, A., Syrris, P., & McKenna, W. J. (2008). Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nature Clinical Practice: Cardiovascular Medicine, 5, 158–168.CrossRefPubMed Keren, A., Syrris, P., & McKenna, W. J. (2008). Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nature Clinical Practice: Cardiovascular Medicine, 5, 158–168.CrossRefPubMed
Zurück zum Zitat Lind, J. M., Chiu, C., & Semsarian, C. (2006). Genetic basis of hypertrophic cardiomyopathy. Expert Review of Cardiovascular Therapy, 4, 927–934.CrossRefPubMed Lind, J. M., Chiu, C., & Semsarian, C. (2006). Genetic basis of hypertrophic cardiomyopathy. Expert Review of Cardiovascular Therapy, 4, 927–934.CrossRefPubMed
Zurück zum Zitat Maron, B. (2002). Hypertrophic Cardiomyopathy, a systematic review. Journal of American Medical Association, 287, 1308–1320.CrossRef Maron, B. (2002). Hypertrophic Cardiomyopathy, a systematic review. Journal of American Medical Association, 287, 1308–1320.CrossRef
Zurück zum Zitat Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109, 2807–2816.CrossRefPubMed Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayés de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109, 2807–2816.CrossRefPubMed
Zurück zum Zitat Marteau, T., & Mitchie, S. (1995). A positive screening test for an untreatable condition provides psychological relief from uncertainty. British Medical Journal, 311, 58–59.PubMed Marteau, T., & Mitchie, S. (1995). A positive screening test for an untreatable condition provides psychological relief from uncertainty. British Medical Journal, 311, 58–59.PubMed
Zurück zum Zitat Michels, M., Hoedemaekers, Y. M., Kofflard, M. J., Frohn-Mulder, I., Dooijes, D., Majoor-Krakauer, D., et al. (2007). Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Netherlands Heart Journal, 15, 184–190.CrossRefPubMed Michels, M., Hoedemaekers, Y. M., Kofflard, M. J., Frohn-Mulder, I., Dooijes, D., Majoor-Krakauer, D., et al. (2007). Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Netherlands Heart Journal, 15, 184–190.CrossRefPubMed
Zurück zum Zitat Morgan, J. F., O’Donoghue, A. C., McKenna, W. J., & Schmidt, M. M. (2008). Psychiatric disorders in hypertrophic cardiomyopathy. General Hospital Psychiatry, 30, 49–54.CrossRefPubMed Morgan, J. F., O’Donoghue, A. C., McKenna, W. J., & Schmidt, M. M. (2008). Psychiatric disorders in hypertrophic cardiomyopathy. General Hospital Psychiatry, 30, 49–54.CrossRefPubMed
Zurück zum Zitat Ritchie, J., Lewis, J., & Elam, G. (2003). Designing and selecting samples. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 77–108). London: Sage. Ritchie, J., Lewis, J., & Elam, G. (2003). Designing and selecting samples. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 77–108). London: Sage.
Zurück zum Zitat Sola, C. L., & Bostwick, J. M. (2005). Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clinic Proceedings, 80, 232–237.CrossRefPubMed Sola, C. L., & Bostwick, J. M. (2005). Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clinic Proceedings, 80, 232–237.CrossRefPubMed
Zurück zum Zitat Spencer, L., Ritchie, J., & O’Connor, W. (2003). Analysis: practices, principles and processes. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 199–218). London: Sage. Spencer, L., Ritchie, J., & O’Connor, W. (2003). Analysis: practices, principles and processes. In J. Ritchie & J. Lewis (Eds.), Qualitative research practice: A guide for social science students and researchers (pp. 199–218). London: Sage.
Zurück zum Zitat van Langen, I. M., Hofman, N., Tan, H. L., & Wilde, A. A. (2004). Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Annals of Medicine, 36(Suppl 1), 116–124.CrossRefPubMed van Langen, I. M., Hofman, N., Tan, H. L., & Wilde, A. A. (2004). Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Annals of Medicine, 36(Suppl 1), 116–124.CrossRefPubMed
Zurück zum Zitat Vincent, G. M. (1998). The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annual Review of Medicine, 49, 263–274.CrossRefPubMed Vincent, G. M. (1998). The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annual Review of Medicine, 49, 263–274.CrossRefPubMed
Zurück zum Zitat Wilson, B. J., Forrest, K., van Teijlingen, E. R., McKee, L., Haites, N., Matthews, E., et al. (2004). Family communication about genetic risk: the little that is known. Community Genetics, 7, 15–24.CrossRefPubMed Wilson, B. J., Forrest, K., van Teijlingen, E. R., McKee, L., Haites, N., Matthews, E., et al. (2004). Family communication about genetic risk: the little that is known. Community Genetics, 7, 15–24.CrossRefPubMed
Zurück zum Zitat Yu, B., French, J. A., Jeremy, R. W., French, P., McTaggart, D. R., Nicholson, M. R., et al. (1997). Counselling issues in familial Hypertrophic Cardiomyopathy. Journal of Medical Genetics, 35, 183–188.CrossRef Yu, B., French, J. A., Jeremy, R. W., French, P., McTaggart, D. R., Nicholson, M. R., et al. (1997). Counselling issues in familial Hypertrophic Cardiomyopathy. Journal of Medical Genetics, 35, 183–188.CrossRef
Metadaten
Titel
Impediments to DNA Testing and Cascade Screening for Hypertrophic Cardiomyopathy and Long QT syndrome: A Qualitative Study of Patient Experiences
verfasst von
Andrew Smart
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 6/2010
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-010-9314-0

Weitere Artikel der Ausgabe 6/2010

Journal of Genetic Counseling 6/2010 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.